本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Akebia Therapeutics, Inc.

1.76
+0.09005.39%
成交量:618.48萬
成交額:1,089.69萬
市值:4.67億
市盈率:-27.16
高:1.84
開:1.69
低:1.67
收:1.67
52周最高:4.08
52周最低:1.52
股本:2.65億
流通股本:2.60億
量比:0.71
換手率:2.38%
股息:- -
股息率:- -
每股收益(TTM):-0.0648
每股收益(LYR):-0.3290
淨資產收益率:-553.45%
總資產收益率:4.80%
市淨率:11.23
市盈率(LYR):-5.35

資料載入中...

2022/03/30

重要事件披露

8-K - Current report
2022/03/01

重要事件披露

8-K - Current report
2022/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/22

重要事件披露

8-K - Current report
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/28

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/01/24

重要事件披露

8-K - Current report
2021/11/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/11/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/01

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/09

重要事件披露

8-K - Current report
2021/09/02

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/09

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/06/03

重要事件披露

8-K - Current report
2021/06/01

重要事件披露

8-K - Current report
2021/05/10

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]